4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-116247
Director sold 13,535 shares at an average $35.16 ($475,879)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kersten Dirk Director | 2024-10-18 | Sale 10b5-1 | −13,414 | $35.16 | $471,636 | 73,225 | I |
| Kersten Dirk Director | 2024-10-21 | Sale 10b5-1 | −121 | $35.06 | $4,242 | 73,104 | I |
| Open-market sales · 13,535 sh · avg $35.16 · $475,879 | |||||||
Loading xslF345X05/ownership.xml…